Pays: Canada
Langue: anglais
Source: Health Canada
DICLOFENAC SODIUM
DOMINION PHARMACAL
M01AB05
DICLOFENAC
100MG
TABLET (EXTENDED-RELEASE)
DICLOFENAC SODIUM 100MG
ORAL
100
Prescription
OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS
Active ingredient group (AIG) number: 0114417001; AHFS:
CANCELLED POST MARKET
2003-07-18
PRODUCT MONOGRAPH Pr DOM-DICLOFENAC (Diclofenac Sodium) 25 and 50 mg Tablets Pr DOM-DICLOFENAC-SR (Diclofenac Sodium) 75 and 100 mg Slow Release Tablets NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) DOMINION PHARMACAL DATE OF REVISION: 6111 Royalmount Ave., Suite 100 April 19, 2010 Montreal, Quebec H4P 2T4 CONTROL NO.: 136993 _ _ _Dom-DICLOFENAC and Dom-DICLOFENAC-SR Product Monograph _ _Page 2 of 36 _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ......................................................... 3 SUMMARY PRODUCT INFORMATION ............................................................................... 3 INDICATIONS AND CLINICAL USE..................................................................................... 3 CONTRAINDICATIONS .......................................................................................................... 4 WARNINGS AND PRECAUTIONS......................................................................................... 5 ADVERSE REACTIONS......................................................................................................... 14 DRUG INTERACTIONS ......................................................................................................... 16 DOSAGE AND ADMINISTRATION..................................................................................... 19 OVERDOSAGE ....................................................................................................................... 21 ACTION AND CLINICAL PHARMACOLOGY ................................................................... 21 STORAGE AND STABILITY................................................................................................. 23 DOSAGE FORMS, COMPOSITION AND PACKAGING ..... ERROR! BOOKMARK NOT DEFINED. PART II: SCIENTIFIC INFORMATION ............................................................................... 25 PHARMACEUTICAL INFORMATION................................................................................. 25 CLINICAL TRIALS.............. Lire le document complet